R&D
Partner Content
2nd Cell Therapy for Autoimmune Disease Summit | Download the BRAND-NEW Program
The 2nd Cell Therapy for Autoimmune Disease Summit returns to …
19701 items found
R&D
Partner Content
6th Cell Therapy Analytical Development Summit | December 3-5, 2024 | Boston, MA
As the field of cell therapy evolves, integrating the latest …
R&D
Partner Content
Unlock the Future of Cell Source and Donor Selection! | 2nd Donor Selection & Cell Source Summit
Join us at the 2nd Donor Selection & Cell Source Summit - an …
News
Servier bags FDA okay for glioma drug from $2bn Agios buy
The FDA has approved Servier's vorasidenib for two forms of glioma, …
R&D
mRNA technologies: Looking beyond COVID vaccines
Following the COVID-19 pandemic, mRNA-based vaccines have been shown …
Digital
AI in the medical devices sector: Fostering innovation while navigating evolving regulations
Among all the changes happening in the healthcare landscape in the …
News
NICE backs osteoporosis drug, but diagnosis is an obstacle
Around 14,000 women in England may soon be able to access a new …
News
Levicept says non-opioid drug cuts arthritis pain in phase 2
A non-opioid drug for pain developed by UK biotech Levicept, with a …
News
BioMarin keeps but scales down Roctavian gene therapy ops
BioMarin Pharma has decided not to divest its haemophilia A gene …
News
Biopharma, finance vets launch $600m life sciences loan firm
There's a new source of funding for life sciences companies in town, …
Patients
Chronic cough and the patient voice
Chronic cough impacts up to 10% of the adult population and has a …
Market Access
Changing Faces May-June 2024: Government, non-profit, and professional organisation
Our fourth Changing Faces round-up is one that we don’t always …
R&D
The role of quality assurance in accelerating drug developme...
The pharmaceutical landscape is experiencing a paradigm shift with the rise of gene therapies, cell therapies, and personalised medicine.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
LSX 2024 - Dr Tadaaki Taniguchi
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
